We play fair by founders
Giving you an unfair advantage, to take you from where you are to where you want to be
Giving you an unfair advantage, to take you from where you are to where you want to be
92% of our portfolio recommend working with us
Story78% of our companies have successfully raised a Series A
PortfolioBecause we know it takes more than funding for a startup to survive and thrive; the right support goes beyond writing cheques
ThesisIt’s a step towards the tomorrow we all want to live in
ContentCollaboration is Queen: Our female founder network has collectively raised £600m
Female FoundersIt’s never too early for an initial conversation
Pitch usData curation to accelerate drug development
Qureight accelerates clinical trial development at key decision points through data curation and AI-powered decision making.
We work with pharmaceutical companies, contract research organisations and hospitals to curate data and help the best drugs get approved: so they can be given to patients who need them the most. We are currently focused on lung and heart disease.
We invested in Dr. Muhunthan Thillai and Dr. Alessandro Ruggiero at Qureight, a data company that is developing the world’s only AI-powered platform dedicated to complex heart and lung diseases, in early 2022. They are building the world’s largest repository of lung and cardiac complex disease data, which is shortening clinical trials, saving pharma companies millions of dollars, and improving patient outcomes.
Read more in our blog post